Concepedia

E F Sharpe

EF

Statistics

Publications

4

Citations

756

H-Index

4

Active since

1996

Affiliations

Eli Lilly (United States)(Current)

Eli Lilly (United Kingdom)

University of Bristol

Therapure Biopharma (Canada)

E F Sharpe is an author at Eli Lilly (United States) specializing in neuroscience, molecular neuroscience, and glutamatergic signaling.

Publications per year

1996–2002

4

Publications

4

A hippocampal GluR5 kainate receptor regulating inhibitory synaptic transmission

Vernon R. J. Clarke, Barbara A. Ballyk, Ken H. Hoo et al. · Nature · 1997 · 416 citations

, , +14

Activity of 2,3-benzodiazepines at Native Rat and Recombinant Human Glutamate Receptors In Vitro : Stereospecificity and Selectivity Profiles

David Bleakman, Barbara A. Ballyk, Darryle D. Schoepp et al. · Neuropharmacology · 1996 · 193 citations

, , +16

Pharmacological discrimination of GluR5 and GluR6 kainate receptor subtypes by (3S,4aR,6R,8aR)-6-[2-(1(2)H-tetrazole-5-yl)ethyl]decahyd roisdoquinoline-3 carboxylic-acid.

R Bleakman, Darryle D. Schoepp, Barbara A. Ballyk et al. · Molecular Pharmacology · 1996 · 104 citations

, , +17

Systemic pre‐treatment with a group II mGlu agonist, LY379268, reduces hyperalgesia <i>in vivo</i>

E F Sharpe, Ann E. Kingston, David Lodge et al. · British Journal of Pharmacology · 2002 · 43 citations · Full text

, , +17

1–4 of 4